Assetmark, Inc Hutchmed (China) LTD Transaction History

Assetmark, Inc

$41.6 Billion
Q2 2025

A detailed history of Assetmark, Inc transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Assetmark, Inc holds 15 shares of HCM stock, worth $231. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$231

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	$11.81 - $17.72 $177 - $265	15 New	15 $0
Q3 2022 Nov 01, 2022	SELL	$8.63 - $15.52 $1,104 - $1,986	-128 Reduced 63.05%	75 $1,000
Q2 2022 Aug 03, 2022	SELL	$8.59 - $20.77 $16,475 - $39,836	-1,918 Reduced 90.43%	203 $3,000
Q1 2022 May 13, 2022	BUY	$15.52 - $35.65 $13,005 - $29,874	838 Added 65.32%	2,121 $40,000
Q4 2021 Feb 14, 2022	BUY	$28.89 - $35.33 $13,202 - $16,145	457 Added 55.33%	1,283 $45,000
Q3 2021 Nov 12, 2021	BUY	$35.66 - $42.94 $1,497 - $1,803	42 Added 5.36%	826 $30,000
Q3 2020 Nov 13, 2020	BUY	$25.8 - $34.61 $4,334 - $5,814	168 Added 27.27%	784 $25,000
Q2 2020 Aug 11, 2020	BUY	$17.65 - $28.05 $458 - $729	26 Added 4.41%	616 $17,000
Q1 2020 May 12, 2020	SELL	$15.19 - $29.51 $835 - $1,623	-55 Reduced 8.53%	590 $11,000
Q4 2019 Feb 11, 2020	SELL	$17.17 - $25.95 $583 - $882	-34 Reduced 5.01%	645 $16,000
Q1 2019 May 14, 2019	SELL	$21.27 - $30.58 $42 - $61	-2 Reduced 0.29%	679 $21,000
Q4 2018 Feb 13, 2019	BUY	$23.09 - $37.69 $15,724 - $25,666	681 New	681 $16,000

Others Institutions Holding HCM

# of Institutions

Shares Held

6.05M

Call Options Held

Put Options Held

Schroder Investment Management Group London, X0

2.58M
Shares

$39.8 Million
0.03% of portfolio
Allianz Asset Management Gmb H Munich, 2M

909K
Shares

$14 Million
0.02% of portfolio
State Street Corp Boston, MA

329K
Shares

$5.08 Million
0.0% of portfolio
Aia Group LTD Hong Kong, K3

315K
Shares

$4.87 Million
0.11% of portfolio
Goldman Sachs Group Inc New York, NY

289K
Shares

$4.46 Million
0.0% of portfolio

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.67B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account